2021-11-16-世界卫生组织-Cervical_cancer_Mali_2021_country_profile_1页_64kb

MALI Cervical Cancer Summary

Burden of Disease

• Crude cervical cancer incidence rate for 2020 was 19.1 per 100,000 women.
• Age-standardized incidence rate for 2020 was 36.4 per 100,000 women.
• Cumulative risk of cervical cancer up to age 74 was 4.2% in 2020.
• Cervical cancer deaths reported were 1,700 in 2019.
• Mortality-to-incidence ratio was 0.73 in 2020.
• Primary risk factors: High HIV incidence (0.73 per 1,000 women aged 15+ years in 2020), tobacco use prevalence among women aged 15+ years was not specified, and condom use at last high-risk sex was not specified for 2018, but related risk factors are noted.

Prevention Strategies

• Primary Prevention (HPV Vaccination):

  • HPV vaccination program was introduced and has not been included in the national vaccination schedule.
  • Vaccination coverage among girls for 2020 was 0%, with no data on first or final doses.
  • Only 0.73% of the target population aged 9-14 received HPV vaccination by age 15.
  • Scale and details not fully specified.

• Secondary Prevention (Screening):

  • A national cervical cancer screening program exists as of 2021.
  • Primary screening test used was not specified in 2021, but a program exists for women aged 30-49 years.
  • Guidelines for strengthening early detection at primary health care level exist, with a defined referral system to secondary and tertiary care.

Treatment and Supportive Care

• National guidelines on cervical cancer management exist from 2021.
• Limited resources: No specific data on radiotherapy or brachytherapy units, medical staff, or facilities per patient (e.g., no radiation oncologists or pathologists specified in 2019-2021 data).
• Palliative care for non-communicable diseases may be available in the public health system, but details are vague.
• For opioid consumption, data is available, but context is unclear (e.g., 0 mg in primary health care facilities).
• Toxicological aspects related to opioids are mentioned, but no specifics on cancer treatment availability.

WHO Elimination Strategy and Other Notes

• WHO cervical cancer elimination targets for 2030 are referenced.
• Data sources include population figures: Female population total was 9,813,000 in 2019, with cervical cancer deaths being 1,700 out of total female deaths (75,500 in 2019).
• Vaccination coverage and screening data indicate limited progress, with HPV not integrated into routine schedules and screening uptake variable.